ARTICLE | Company News
Pfizer exercises NicOx option
November 23, 2005 1:00 AM UTC
PFE exercised its option to license an NO-donating compound from NicOx (Euronext:Nicox) under a 2004 deal. The compound is in preclinical development to treat an undisclosed ophthalmic indication. Nic...